Maat Pharma (XPAR:MAAT) EPS (Basic) : €-2.20 (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Maat Pharma EPS (Basic)?

Maat Pharma's basic earnings per share (Basic EPS) for the six months ended in Dec. 2024 was €-1.15. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was €-2.20.

Maat Pharma's EPS (Diluted) for the six months ended in Dec. 2024 was €-1.15. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was €-2.20.

Maat Pharma's EPS without NRI for the six months ended in Dec. 2024 was €-1.15. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was -2.20.

During the past 3 years, the average EPS without NRI Growth Rate was 15.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was -31.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 7 years, Maat Pharma's highest 3-Year average EPS without NRI Growth Rate was 15.90% per year. The lowest was -98.90% per year. And the median was -41.60% per year.

Maat Pharma EPS (Basic) Historical Data

The historical data trend for Maat Pharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maat Pharma EPS (Basic) Chart

Maat Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

-0.56

-3.70

-1.40

-1.70

-2.20

Maat Pharma Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
EPS (Basic)	Get a 7-Day Free Trial							-0.60	-0.76	-0.94	-1.05	-1.15

Maat Pharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Maat Pharma's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-28.904	-	0)	/	13.065
	=	-2.21

Maat Pharma's Basic EPS for the quarter that ended in Dec. 2024 is calculated as

Basic EPS (Q: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-16.048	-	0)	/	13.934
	=	-1.15

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-2.20

Maat Pharma (XPAR:MAAT) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Maat Pharma EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Maat Pharma's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Maat Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maat Pharma SA (XPAR:MAAT) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

4RD:Germany

Address

70 Avenue Tony Garnier, Lyon, FRA, 69007

Website

https://www.maatpharma.com

Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.

Maat Pharma Headlines

No Headlines